TABLE 3.

Effects of several blood lipids, lipoproteins and apolipoproteins on Bell’s palsy risk using IVW and MR-Egger in the study.

Exposures	Methods	No. of SNP	OR (95%CI)	p-Value for MR	p-Value for heterogeneity a	p-Value for horizontal pleiotropy a
Triglycerides	IVW	220	1.034 (0.872–1.228)	0.698	0.511	0.479
	MR-Egger	220	0.968 (0.753–1.244)	0.799
LDL cholesterol	IVW	121	0.836 (0.678–1.031)	0.094	0.114	0.975
	MR-Egger	121	0.833 (0.614–1.130)	0.242
Removing rs497083	IVW	120	0.805 (0.649–0.998)	0.048	0.129	0.823
	MR-Egger	120	0.784 (0.573–1.074)	0.132
HDL cholesterol	IVW	250	0.900 (0.763–1.062)	0.213	0.575	0.649
	MR-Egger	250	0.940 (0.733–1.204)	0.624
Apolipoprotein A-I	IVW	216	0.987 (0.818–1.191)	0.891	0.096	0.250
	MR-Egger	216	1.130 (0.839–1.522)	0.421
Apolipoprotein B	IVW	134	0.817 (0.687–0.972)	0.023	0.366	0.601
	MR-Egger	134	0.851 (0.675–1.071)	0.172
Removing rs143020224	IVW	133	0.844 (0.706–1.010)	0.063	0.391	0.463
	MR-Egger	133	0.896 (0.705–1.138)	0.370
Lipoprotein A	IVW	12	1.000 (0.998–1.001)	0.775	0.388	0.320
	MR-Egger	12	1.000 (0.998–1.002)	0.692

^a Heterogeneity was assessed using the Cochran’s Q test, and horizontal pleiotropy was assessed using the MR-Egger intercept test.